Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study’s locations were updated with many new enrollment sites across China (e.g., Hangzhou, Shanghai, Chengdu, Jinan, Nanjing, Shenyang, Qingdao, Hangzhou again) and other regions, while a large number of previously listed sites were removed, resulting in a larger overall footprint (up to 380 locations) compared to before.
    Difference
    4%
    Check dated 2026-08-15T11:20:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer release. There is no indication of user-facing content changes to study details or page layout.
    Difference
    0.0%
    Check dated 2026-08-08T03:58:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3, signaling a minor page-version update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-24T22:17:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new platform revision tag v3.6.3 was added, replacing v3.6.2, indicating a software update rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-07-03T14:51:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    New recruitment, sponsor, and study-document links were added to the Study Details page. Items include BMS Clinical Trial Patient Recruiting, BMS Clinical Trial Information, Mirati Therapeutics Inc., and a PDF of the Study Protocol and Statistical Analysis Plan, along with IPD data-sharing notes.
    Difference
    100%
    Check dated 2026-06-26T10:22:26.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Enrollment status updated to indicate no recruitment; new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision label updated to v3.6.0, with a formatting adjustment to the Intervention/Treatment heading.
    Difference
    0.1%
    Check dated 2026-06-11T22:50:44.000Z thumbnail image

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.